RCT | Oral fluvoxamine plus inhaled budesonide reduced hospitalizations in high-risk patients with early-onset COVID-19

Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19: A Randomized Platform Trial – Annals of Internal Medicine

Commentary: Combination of fluvoxamine and inhaled budesonide reduces severe COVID-19 in high-risk outpatients – News Medical

Commentary on Twitter

Treatment w/ oral fluvoxamine + inhaled budesonide among high-risk outpatients w/ early #COVID19 reduced incidence of severe disease requiring advanced care. The combined effect seems to offer benefits over individual use of each drug: https://t.co/wM2da5a5MD pic.twitter.com/Sl1qFzTOjD

— Annals of Int Med (@AnnalsofIM) April 19, 2023